NASDAQ:VCNX Vaccinex Earnings Date & Estimates $1.02 +0.02 (+2.00%) As of 11:56 AM Eastern Vaccinex is estimated to report earnings on Wednesday, November 18, 2026. Research:Profile Upcoming Earnings Announcement Announcement DateNovember 18, 2026 Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from VaccinexVaccinex is expected to post earnings of -$73.0380 per share on revenue of $333 thousand.Consensus EstimatesConsensus EPS-$73.0380Expected Revenue$333 thousandRecent Track RecordLast ReportedQ2 2024Last Quarter EPS-$3.10Last Quarter Revenue$230 thousandPrepare for the Earnings CallCompany ProfileQ2 2024 Earnings ReportQ1 2024 Earnings ReportQ4 2023 Earnings Report Vaccinex Earnings FAQ When does Vaccinex report earnings? Vaccinex (NASDAQ:VCNX) is estimated to report earnings on Wednesday, November 18, 2026. This date is estimated from past reporting schedules and may change once the company confirms it. What is the consensus EPS estimate for Vaccinex? Analysts expect Vaccinex to post earnings of -$73.0380 per share for the quarter. How much revenue is Vaccinex expected to report? The consensus revenue estimate for Vaccinex is $333 thousand for the quarter. Vaccinex Earnings HeadlinesVaccinex (VCNX) Projected to Announce Quarterly Earnings on MondayNovember 15 at 10:21 AM | americanbankingnews.comSEMA4D Blockade Reshapes the Tumor Immune Environment in Neoadjuvant Melanoma StudyOctober 7, 2026 | globenewswire.comWorse than socialismDonald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same economic system, according to veteran analyst Porter Stansberry. The government has already taken stakes in companies like Intel, Lithium Americas, and MP Materials, while political rhetoric on both sides points toward deeper centralization. Stansberry has spent months investigating what this bipartisan shift could mean for investors navigating the months ahead.November 18 at 1:00 AM | Porter & Company (Ad)Vaccinex to Report New Biomarker Data and Plans for Phase 2B Clinical Trial of Pepinemab in AD at the Alzheimer's Association International Conference in London on July 13, 2026July 8, 2026 | globenewswire.comVaccinex, Inc. Reports Financial Results for Year Ended December 31, 2025April 29, 2026 | quiverquant.comQVaccinex Reports 2025 Annual Financial ResultsApril 29, 2026 | globenewswire.comSee More Vaccinex Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Vaccinex? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vaccinex and other key companies, straight to your email. Email Address About VaccinexVaccinex (NASDAQ:VCNX) is a biotechnology company focused on developing antibody-based treatments for cancer and neurological diseases. Its research centers on semaphorin 4D (SEMA4D), a protein involved in immune regulation and tissue responses. The company’s lead drug candidate, pepinemab, is an investigational monoclonal antibody designed to block SEMA4D. Vaccinex has studied the treatment in clinical programs for conditions including cancer and Huntington’s disease; it does not have an approved commercial product. Based in Rochester, New York, Vaccinex was founded in 2001. Its work has also included the ActivMAb platform, a technology for discovering and developing therapeutic antibodies.View Vaccinex ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles NVIDIA's Earnings Were Strong, But Can the Next CEO Keep the Momentum Going?5 Consumer Discretionary Plays Showing Strength During the Tech Sell-OffAMD Bets $8.2B on Physical AI: Could Robotics Be Its Next Growth Frontier?Disney Has the Magic Touch: Dividend Growth and Buybacks Could Fuel a BreakoutAmazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its YearThe Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to WatchTyson Foods' Earnings Beat Hides a Warning for Consumer Staples Dividend Investors Upcoming Earnings NetEase (11/19/2026)Alibaba Group (11/19/2026)PDD (11/19/2026)Ross Stores (11/19/2026)Walmart (11/19/2026)Intuit (11/19/2026)Hewlett Packard Enterprise (11/23/2026)Medtronic (11/24/2026)Analog Devices (11/24/2026)Autodesk (11/24/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.